{"name":"Lantheus Holdings","slug":"lantheus","ticker":"LNTH","exchange":"NASDAQ","domain":"lantheus.com","description":"Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions usin","hq":"North Billerica, MA","founded":0,"employees":"1193","ceo":"","sector":"Radiopharmaceutical Diagnostics","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":95.94,"stockChange":-0.52,"stockChangePercent":-0.54,"marketCap":"$6.2B","metrics":{"revenue":1546178048,"revenueGrowth":1.2,"grossMargin":60.5,"rdSpend":0,"netIncome":279031008,"cash":498582016,"dividendYield":0,"peRatio":22.9,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":1541609000,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":1541609000},{"period":"2024-12-31","value":1533910000},{"period":"2023-12-31","value":1296429000},{"period":"2022-12-31","value":935061000}],"grossProfit":941952000,"grossProfitHistory":[{"period":"2025-12-31","value":941952000},{"period":"2024-12-31","value":988291000},{"period":"2023-12-31","value":709543000},{"period":"2022-12-31","value":581703000}],"rdSpend":177308000,"rdSpendHistory":[{"period":"2025-12-31","value":177308000},{"period":"2024-12-31","value":168098000},{"period":"2023-12-31","value":77707000},{"period":"2022-12-31","value":311681000}],"sgaSpend":453812000,"operatingIncome":315559000,"operatingIncomeHistory":[{"period":"2025-12-31","value":315559000},{"period":"2024-12-31","value":448564000},{"period":"2023-12-31","value":364642000},{"period":"2022-12-31","value":36195000}],"netIncome":233559000,"netIncomeHistory":[{"period":"2025-12-31","value":233559000},{"period":"2024-12-31","value":312442000},{"period":"2023-12-31","value":326661000},{"period":"2022-12-31","value":28067000}],"eps":3.41,"epsHistory":[{"period":"2025-12-31","value":3.41},{"period":"2024-12-31","value":4.36},{"period":"2023-12-31","value":4.65},{"period":"2022-12-31","value":0.4}],"cash":359121000,"cashHistory":[{"period":"2025-12-31","value":359121000},{"period":"2024-12-31","value":912814000},{"period":"2023-12-31","value":713656000},{"period":"2022-12-31","value":415652000}],"totalAssets":2227399000,"totalLiabilities":1137602000,"totalDebt":619432000,"equity":1089797000,"operatingCashflow":390141000,"operatingCashflowHistory":[{"period":"2025-12-31","value":390141000},{"period":"2024-12-31","value":544750000},{"period":"2023-12-31","value":305260000},{"period":"2022-12-31","value":281781000}],"capex":-41502000,"capexHistory":[{"period":"2025-12-31","value":-41502000},{"period":"2024-12-31","value":-79625000},{"period":"2023-12-31","value":-46555000},{"period":"2022-12-31","value":-18347000}],"freeCashflow":348639000,"dividendsPaid":null,"buybacks":-300017000,"employees":1193,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":116211000,"ebit":75443000,"ebitda":98276000,"period":"2025-12-31","revenue":406786000,"epsBasic":0.82,"netIncome":54088000,"rdExpense":47480000,"epsDiluted":0.82,"grossProfit":240875000,"operatingIncome":77184000},{"sga":130726000,"ebit":47331000,"ebitda":67739000,"period":"2025-09-30","revenue":384014000,"epsBasic":0.41,"netIncome":27771000,"rdExpense":48025000,"epsDiluted":0.41,"grossProfit":222366000,"operatingIncome":43615000},{"sga":107556000,"ebit":109434000,"ebitda":122665000,"period":"2025-06-30","revenue":378045000,"epsBasic":1.15,"netIncome":78755000,"rdExpense":45489000,"epsDiluted":1.12,"grossProfit":241011000,"operatingIncome":87966000},{"sga":99319000,"ebit":101333000,"ebitda":114959000,"period":"2025-03-31","revenue":372764000,"epsBasic":1.06,"netIncome":72945000,"rdExpense":36314000,"epsDiluted":1.02,"grossProfit":237700000,"operatingIncome":106794000},{"sga":101509000,"ebit":4262000,"ebitda":21547000,"period":"2024-12-31","revenue":391110000,"epsBasic":-0.17,"netIncome":-11790000,"rdExpense":35325000,"epsDiluted":-0.17,"grossProfit":248545000,"operatingIncome":111711000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":95.94,"previousClose":96.46,"fiftyTwoWeekHigh":98.27,"fiftyTwoWeekLow":47.25,"fiftyTwoWeekRange":"47.25 - 98.27","fiftyDayAverage":81.61,"twoHundredDayAverage":65.83,"beta":-0.08,"enterpriseValue":6407302656,"forwardPE":15,"priceToBook":5.15,"priceToSales":4.04,"enterpriseToRevenue":4.14,"enterpriseToEbitda":17.49,"pegRatio":0,"ebitda":366256000,"ebitdaMargin":23.7,"freeCashflow":421714496,"operatingCashflow":407704992,"totalDebt":625752000,"debtToEquity":51.6,"currentRatio":2.83,"returnOnAssets":8.2,"returnOnEquity":23.5,"analystRating":"1.5 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":13,"targetMeanPrice":104.08,"targetHighPrice":117,"targetLowPrice":76,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":2,"institutionHeldPercent":111,"sharesOutstanding":65106082,"floatShares":58551853,"sharesShort":5671957,"shortRatio":8.19,"shortPercentOfFloat":8.7,"epsTrailing":4.19,"epsForward":6.37,"revenuePerShare":23.25,"bookValue":18.63,"officers":[{"age":65,"name":"Ms. Mary Anne Heino","title":"Interim CEO & Executive Chairperson"},{"age":58,"name":"Mr. Robert J. Marshall Jr., CFA","title":"CFO & Treasurer"},{"age":48,"name":"Mr. Daniel M. Niedzwiecki","title":"Chief Administrative Officer, General Counsel & Corporate Secretary"},{"age":46,"name":"Ms. Amanda M. Morgan","title":"Chief Commercial Officer"},{"age":62,"name":"Dr. Ludger  Dinkelborg Ph.D.","title":"Head of Research & Development"},{"age":null,"name":"Mr. Neil  Holland","title":"Vice President of Business Insights & Operations"},{"age":34,"name":"Ms. Kimberly  Brown","title":"Chief Accounting Officer"},{"age":null,"name":"Ms. Dorothy  Barr","title":"Senior Vice President of Manufacturing & Technical Operations"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.lantheus.com","phone":"978 671 8001"}}